Wild-type and attenuated influenza virus infection of the neonatal rat brain
- PMID: 15385253
- DOI: 10.1080/13550280490499579
Wild-type and attenuated influenza virus infection of the neonatal rat brain
Abstract
Although influenza virus infection of humans has been associated with a wide spectrum of clinical neurological syndromes, the pathogenesis of influenza virus associated central nervous system (CNS) disease in humans remains controversial. To better study influenza virus neuropathogenesis, an animal model of influenza-associated CNS disease using human virus isolates without adaptation to an animal host was developed. This neonatal rat model of influenza virus CNS infection was developed using low-passage human isolates and shows outcomes in specific brain regions, cell types infected, and neuropathological outcomes that parallel the available literature on cases of human CNS infection. The degree of virus replication and spread in the rat brain correlated with the strains' neurotoxicity potential for humans. In addition, using sensitive neurobehavioral test paradigms, changes in brain function were found to be associated with areas of virus replication in neurons. These data suggest that further evaluation of this pathogenesis model may provide important information regarding influenza virus neuropathogenesis, and that this model may have possible utility as a preclinical assay for evaluating the neurological safety of new live attenuated influenza virus vaccine strains.
Similar articles
-
Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.J Virol. 1998 Oct;72(10):8037-42. doi: 10.1128/JVI.72.10.8037-8042.1998. J Virol. 1998. PMID: 9733843 Free PMC article.
-
Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.Vaccine. 2014 Jan 23;32(5):535-43. doi: 10.1016/j.vaccine.2013.12.002. Epub 2013 Dec 14. Vaccine. 2014. PMID: 24342248
-
Attenuated influenza virus vaccines with modified NS1 proteins.Curr Top Microbiol Immunol. 2009;333:177-95. doi: 10.1007/978-3-540-92165-3_9. Curr Top Microbiol Immunol. 2009. PMID: 19768406 Review.
-
The infant rat as a model for assessment of the attenuation of human influenza viruses.J Med Microbiol. 1979 Feb;12(1):43-54. doi: 10.1099/00222615-12-1-43. J Med Microbiol. 1979. PMID: 311833
-
Flu myths: dispelling the myths associated with live attenuated influenza vaccine.Mayo Clin Proc. 2008 Jan;83(1):77-84. doi: 10.4065/83.1.77. Mayo Clin Proc. 2008. PMID: 18174020 Review.
Cited by
-
Recapitulating influenza virus infection and facilitating antiviral and neuroprotective screening in tractable brain organoids.Theranostics. 2022 Jul 7;12(12):5317-5329. doi: 10.7150/thno.75123. eCollection 2022. Theranostics. 2022. PMID: 35910807 Free PMC article.
-
Live Viral Vaccine Neurovirulence Screening: Current and Future Models.Vaccines (Basel). 2021 Jun 30;9(7):710. doi: 10.3390/vaccines9070710. Vaccines (Basel). 2021. PMID: 34209433 Free PMC article. Review.
-
Genetic contributions to influenza virus attenuation in the rat brain.J Neurovirol. 2008 Apr;14(2):136-42. doi: 10.1080/13550280701885563. J Neurovirol. 2008. PMID: 18444085
-
Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.PLoS One. 2012;7(12):e51068. doi: 10.1371/journal.pone.0051068. Epub 2012 Dec 10. PLoS One. 2012. PMID: 23251423 Free PMC article.
-
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.Biologics. 2010 Sep 13;4:245-61. doi: 10.2147/btt.s12097. Biologics. 2010. PMID: 20859452 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources